-
1دورية أكاديمية
المؤلفون: Liu, Guozheng, Zhang, Yanwen, Huang, Yong
المصدر: European Journal of Cancer Care; 4/8/2024, Vol. 2024, p1-12, 12p
مصطلحات موضوعية: BREAST cancer prognosis, THERAPEUTIC use of antineoplastic agents, BREAST tumor treatment, THERAPEUTIC use of monoclonal antibodies, ANTIANDROGENS, MITOGEN-activated protein kinases, CANCER relapse, T cells, TRASTUZUMAB, BREAST tumors, IMMUNOTHERAPY, PROGRAMMED death-ligand 1, APOPTOSIS, ENZYME inhibitors, AGE distribution, TUMOR markers, METASTASIS, ADJUVANT chemotherapy, IMMUNE checkpoint inhibitors, COMBINED modality therapy, PROGRAMMED cell death 1 receptors, MTOR inhibitors, PROGRESSION-free survival, INDIVIDUALIZED medicine, PHENOTYPES, OVERALL survival
-
2دورية أكاديمية
المؤلفون: Guan, Shuyuan, Sun, Lingbin, Wang, Xihua, Huang, Xirui, Luo, Tao
المصدر: Evidence-based Complementary & Alternative Medicine (eCAM); 11/23/2022, p1-8, 8p, 1 Diagram, 5 Graphs
مصطلحات موضوعية: LIPOPOLYSACCHARIDES, RODENTS, CYTOKINES, INTERLEUKINS, CYCLOOXYGENASE 2, IN vitro studies, FLAVONOIDS, NITRIC-oxide synthases, ANTI-inflammatory agents, ANIMAL experimentation, NONSTEROIDAL anti-inflammatory agents, METABOLISM, METABOLIC reprogramming, PHOSPHATASES, MTOR inhibitors, NEUROINFLAMMATION, GENE expression, DNA-binding proteins, TUMOR necrosis factors, TRANSFERASES, NEUROGLIA, PLANT extracts, CELL lines, NITRIC oxide, MITOGEN-activated protein kinases, PHOSPHORYLATION, PHARMACODYNAMICS, CHEMICAL inhibitors